Related Experiment Video

Updated: Oct 9, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

614

Iron chelation therapy in patients with low- to intermediate-risk myelodysplastic syndrome: A systematic review and

Sarah Yang1, Ming Chan Zhang2, Russell Leong3

  • 1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

British Journal of Haematology
|December 20, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
iron chelation therapyiron overloadmyelodysplastic syndromeoverall survivalrandomised controlled trials

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.7K

Related Concept Videos